StockData
Neuraxis, INC logo

Neuraxis, INC (NRXS) stock

NRXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 0/30
$4.61−0.19 (-3.96%)

Close on Nov 17, 2026Market cap $57.89MP/E –Yield –

Neuraxis ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Neuraxis's ebitda for the twelve months ending Jun 30, 2026 was -$7.61M. For fiscal 2025 it was -$7.77M.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$7.77M–
FY2024Dec 31, 2024-$7.12M–
FY2023Dec 31, 2023-$6.62M–
FY2022Dec 31, 2022-$3.34M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$2.11M–
Q1 FY2026Mar 31, 2026-$1.72M–
Q4 FY2025Dec 31, 2025-$1.69M–
Q3 FY2025Sep 30, 2025-$2.08M–
Q2 FY2025Jun 30, 2025-$1.70M–
Q1 FY2025Mar 31, 2025-$2.29M–
Q4 FY2024Dec 31, 2024-$1.46M–
Q3 FY2024Sep 30, 2024-$1.64M–
Q2 FY2024Jun 30, 2024-$2.20M–
Q1 FY2024Mar 31, 2024-$1.82M–
Q4 FY2023Dec 31, 2023-$1.61M–
Q3 FY2023Sep 30, 2023-$3.01M–
Q2 FY2023Jun 30, 2023-$1.11M–
Q1 FY2023Mar 31, 2023-$886.43K–
Q4 FY2022Dec 31, 2022-$974.14K–
Q3 FY2022Sep 30, 2022-$1.19M–

More Neuraxis figures

See a number that looks wrong?